# Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery

> **NCT01509118** · — · UNKNOWN · sponsor: **Phramongkutklao College of Medicine and Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Open Fracture of Hip

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01509118
- **Lead sponsor:** Phramongkutklao College of Medicine and Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2013-06
- **Final completion:** 2013-09
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2012-01-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01509118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01509118, "Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01509118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*